Smoking increases the risk of extraintestinal manifestations in Crohn's disease

World Journal of Gastroenterology

Volumn 20, Issue 34, 2014, Pages 12269-12276

  Ott, Claudia ^a   Takses, Angela ^a   Obermeier, Florian ^a   Schnoy, Elisabeth ^a   Müller, Martina ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Age at onset; Crohn's disease; Extraintestinal manifestations; Smoking; Surgery; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; MESALAZINE; METHOTREXATE;

ADULT; ARTHROPATHY; ARTICLE; COHORT ANALYSIS; CONJUNCTIVITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; EPISCLERITIS; ERYTHEMA NODOSUM; EVALUATION STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROSPECTIVE STUDY; PYODERMA GANGRENOSUM; RISK FACTOR; SACROILIITIS; SMOKING; ULCERATIVE COLITIS; UVEITIS; ADVERSE EFFECTS; AGE; COLITIS, ULCERATIVE; DISEASE COURSE; GERMANY; PREDICTIVE VALUE; PROGNOSIS; RISK; RISK ASSESSMENT; STATISTICAL MODEL; TIME;

ADULT; AGE FACTORS; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS;

EID: 84909629459     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i34.12269     Document Type: Article

References (37)

1. Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol 2013; 10: 585-595 [PMID: 23835489 DOI: 10.1038/nrgastro.2013.117]
2. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 307-327 [PMID: 12122740]
3. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001; 96: 1116-1122 [PMID: 11316157]
4. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106: 110-119 [PMID: 20808297 DOI: 10.1038/ajg.2010.343]
5. Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis 2004; 10: 207-214 [PMID: 15290913]
6. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412 [PMID: 957999]
7. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34 [PMID: 8835896]
8. Löfberg R, Louis EV, Reinisch W, Robinson AM, Kron M, Camez A, Pollack PF. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE. Inflamm Bowel Dis 2012; 18: 1-9 [PMID: 21351211 DOI: 10.1002/ibd.21663]
9. Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Inflamm Bowel Dis 2008; 14 Suppl 2: S198-S199 [PMID: 18816779 DOI: 10.1002/ibd.20597]
10. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20: 1691-1695 [PMID: 16246187]
11. Cao Q, Si JM, Gao M, Zhou G, Hu WL, Li JH. Clinical presentation of inflammatory bowel disease: a hospital based retrospective study of 379 patients in eastern China. Chin Med J (Engl) 2005; 118: 747-752 [PMID: 15899137]
12. Arora G, Singh G, Vadhavkar S, Shah SB, Mannalithara A, Mithal A, Triadafilopoulos G. Incidence and risk of intestinal and extra-intestinal complications in Medicaid patients with inflammatory bowel disease: a 5-year population-based study. Dig Dis Sci 2010; 55: 1689-1695 [PMID: 20428948]
13. Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 2008; 20: 917-923 [PMID: 18794607 DOI: 10.1097/MEG.0b013e3282f97b33]
14. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, Ding Y, Luo H, Hou W, Zhao Q, Liu N, Ren H, Hou X, Xu H. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006; 12: 212-217 [PMID: 16534423]
15. Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol 2006; 101: 1012-1023 [PMID: 16696785]
16. White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, Cohen SA, Baldassano RN, Smith T, Clemons T, Gold BD. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterol Hepatol 2008; 6: 1361-1369 [PMID: 18848910 DOI: 10.1016/j.cgh.2008.07.032]
17. Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña S. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 2007; 19: 73-78 [PMID: 17206080]
18. Repiso A, Alcántara M, Muñoz-Rosas C, Rodríguez-Merlo R, Pérez-Grueso MJ, Carrobles JM, Martínez-Potenciano JL. Extraintestinal manifestations of Crohn's disease: prevalence and related factors. Rev Esp Enferm Dig 2006; 98: 510-517 [PMID: 17022700]
19. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003; 9: 2300-2307 [PMID: 14562397]
20. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988; 148: 297-302 [PMID: 3277559]
21. Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome? World J Gastroenterol 2011; 17: 2702-2707 [PMID: 21734777 DOI: 10.3748/wjg.v17.i22.2702]
22. Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2008; 46: 124-133 [PMID: 18223370 DOI: 10.1097/MPG.0b013e318093f4b0]
23. Salvarani C, Vlachonikolis IG, van der Heijde DM, Fornaciari G, Macchioni P, Beltrami M, Olivieri I, Di Gennaro F, Politi P, Stockbrügger RW, Russel MG. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001; 36: 1307-1313 [PMID: 11761022]
24. Das KM. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig Dis Sci 1999; 44: 1-13 [PMID: 9952216]
25. Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 2008; 87: 281-293 [PMID: 18794711 DOI: 10.1097/MD.0b013e318187cc9c]
26. Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, Griga T. Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol 2001; 39: 137-144 [PMID: 11253504]
27. Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol 2002; 29: 511-515 [PMID: 11908564]
28. Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D, Asproudis I, Tsianos EV. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 2009; 15: 29-34 [PMID: 18626979 DOI: 10.1002/ibd.20584]
29. Monsén U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol 1990; 85: 711-716 [PMID: 2353691]
30. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38: 738-741 [PMID: 8707121]
31. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13: 1403-1411 [PMID: 10571595]
32. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52: 552-557 [PMID: 12631668]
33. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003; 98: 363-368 [PMID: 12591056]
34. Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779-782 [PMID: 1624159]
35. Lakatos PL, Szalay F, Tulassay Z, Molnar T, Kovacs A, Gasztonyi B, Papp J, Lakatos L. Clinical presentation of Crohn' s disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepatogastroenterology 2005; 52: 817-822 [PMID: 15966211]
36. Manguso F, Sanges M, Staiano T, Gargiulo S, Nastro P, Gargano D, Somma P, Mansueto G, Peluso R, Scarpa R, D'Armiento FP, Astarita C, Ayala F, Renda A, Mazzacca G, D'Arienzo A. Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis. Am J Gastroenterol 2004; 99: 327-334 [PMID: 15046225]
37. Yi F, Chen M, Huang M, Li J, Zhao J, Li L, Xia B. The trend in newly diagnosed Crohn's disease and extraintestinal manifestations of Crohn's disease in central China: a retrospective study of a single center. Eur J Gastroenterol Hepatol 2012; 24: 1424-1429 [PMID: 22895389 DOI: 10.1097/MEG.0b013e3283583e5c]